Histamine has an important role in the regulation of normal function and the changes which occur as a result of trauma and inflammation. It is one of the principal constituents of tissue mast cells' and blood basophils2, and it is also found in gastric mucosa,3 vascular endothelial,4 and smooth muscle cells. 5 The kidney synthesises and stores histamine,6 but very little is known about the role of histamine in renal pathophysiology. Prior treatment of rats with experimental induced glomerular nephritis with HI receptor antagonists reduced the degree of proteinuria and onset of the disease. 7 
Methods
We studied 38 patients with renal disease in the following four clinical groups: Group 1 Nine patients with nephrotic syndrome (six men, three women; median age 27 years, range 18-60 years). The median duration of nephrotic syndrome was six years (range one to 32 years). The median 24 hour urinary albumin excretion was 10 3 g (range 5-7-14-2 g), median plasma albumin 38 g (range 32-47 g), median plasma creatinine 101 4umol/l (range 68-208 Mumol/l), median plasma cholesterol 7-3 mmol/l (range 5-2-15-7 mmol/l). The diagnosis in these patients was minimal change glomerular nephritis in three, membranous glomerular nephritis in one, focal sclerosing glomerulonephritis in three, systemic lupus erythematosus in one, and amyloidosis in one. None of the patients was taking corticosteroids, two were hypertensive, and both of these were being treated with beta blockers. Group 2 Nine patients with end stage renal failure five men, four women; median age 54 (range 23-62 years) with plasma creatinine concentrations of more than 400 umol/l, median creatinine clearance 690 jmol/l (500-1213 umol/l). None of these patients had had dialysis. All nine patients were hypertensive and were being treated with nifedipine and diuretics; four patients were also taking metoprolol and one captopril. All patients were taking ranitidine. One patient had evidence of peripheral vascular disease. One patient had had a renal transplantation which had failed due to chronic vascular rejection. Group 3 Ten patients (five men, five women) who were receiving continuous ambulatory peritoneal dialysis (median age 57 years, range 41-62 years). The median duration of dialysis was one year (range six months to three years). Three patients had evidence of peripheral vascular disease, two others were insulin dependent diabetics (one with retinopathy), two patients were hypertensive and both were taking nifedipine. All 
ASSAY OF HISTAMINE IN PLASMA
Plasma histamine concentrations were determined using a sensitive and specific monoclonal antibody radioimmunoassay for histamine. '4 The assay entails the "acylation" of histamine into a succinyl-glycinamide derivative, and the histamine determination makes use of the competition of acylated histamine and 125I acylated histamine for their binding to the mouse monoclonal antibody fixed on tubes. The lower limit of sensitivity in this RIA was 0-1 nmol/f for histamine and the standard curve permitted measurements between 0-1 nmol/l and 150 nmol/l. Intra-assay and interassay variations have been described previously.'5 Statistical analysis was carried out using the Mann-Whitney (two-tailed) U test for unpaired data.
Results
Plasma histamine concentrations in the two groups of control subjects were unaffected by age. Thus plasma histamine concentrations in young subjects were median 0-78, range 0 49 to 1-80 nmol/l, and in elderly subjects were median 0-67, range 0-31-2-22 nmol/l). There were no age related differences in plasma histamine concentrations in any of the patient groups. Therefore, for purposes of statistical analysis, the entire group of control subjects was regarded as one.
Plasma histamine concentrations are shown in the figure. The clinical and biochemical indices of the patient groups are shown in the Plasma histamine in patients with chronic renalfailure and nephrotic syndrome ingly, some of the highest plasma histamine concentrations were in patients with concomitant peripheral vascular disease. The two highest histamine values were both in patients with severe peripheral vascular disease, and both of whom had pruritus. The median histamine concentrations in patients with peripheral vascular disease, however, were not significantly greater than those in patients without peripheral vascular disease. There were no significant correlations between histamine and creatinine clearance, plasma creatinine, plasma albumin and urinary albumin in any of the patient groups. Furthermore, there were no significant correlations between histamine, renal function, and lipid profiles in the patient groups.
Discussion
Our data clearly show a substantial increase in histamine concentrations in plasma obtained from patients with both nephrotic syndrome and chronic renal failure. This increase is similar to that previously reported,'2 but two of our patients had very high plasma histamine concentrations and interestingly both had severe pruritus. The increase in plasma histamine concentrations may be due to renal insufficiency in patients with chronic renal failure because histamine, a relatively small hydrophilic molecule, is normally excreted in the urine.'6 It is also known that parathyroid hormone, which is grossly increased in chronic renal failure, causes histamine to be released from mast cells which in turn are found in larger numbers in the skin of patients with chronic renal failure. ' 
